In this issue of Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of Current and Next Generation Therapeutics in Hepatology. Top experts in hepatology provide updates on the latest pharmaceuticals available as well as those in the pipeline for a wide range of liver diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Liver-Directed Molecular Therapies: Current and Upcoming Strategies - p. 583 9. New Approaches to Alcohol-Associated Hepatitis - p. 595 10. Therapies and Pipeline for Hepatitis B and Hepatitis D - p. 627 11. Recent Advances in Primary Biliary Cholangitis Treatment - p. 641 12. Current Status and Future Directions in the Pharmacologic Management of Cirrhosis - p. 657 13. Novel Therapeutics for Hepatocellular Carcinoma - p. 673 14. Current Focus and Innovation in Liver Transplantation - p. 697 15. Radiomics in Hepatology: Therapeutic Applications in Hepatocellular Carcinoma - p. 717 16. Current and Future Implications of Weight Loss Drugs on Liver Disease - p. 743 17. Artificial Intelligence and Machine Learning Applications in Liver Disease - p. 755 18. Pediatric Liver Diseases: Next-Generation Therapies - p. 771 19. Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus - p. 781
In this issue of Clinics in Liver Disease, guest editor Dr. Vinod K. Rustgi brings his considerable expertise to the topic of Current and Next Generation Therapeutics in Hepatology. Top experts in hepatology provide updates on the latest pharmaceuticals available as well as those in the pipeline for a wide range of liver diseases.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Liver-Directed Molecular Therapies: Current and Upcoming Strategies - p. 583 9. New Approaches to Alcohol-Associated Hepatitis - p. 595 10. Therapies and Pipeline for Hepatitis B and Hepatitis D - p. 627 11. Recent Advances in Primary Biliary Cholangitis Treatment - p. 641 12. Current Status and Future Directions in the Pharmacologic Management of Cirrhosis - p. 657 13. Novel Therapeutics for Hepatocellular Carcinoma - p. 673 14. Current Focus and Innovation in Liver Transplantation - p. 697 15. Radiomics in Hepatology: Therapeutic Applications in Hepatocellular Carcinoma - p. 717 16. Current and Future Implications of Weight Loss Drugs on Liver Disease - p. 743 17. Artificial Intelligence and Machine Learning Applications in Liver Disease - p. 755 18. Pediatric Liver Diseases: Next-Generation Therapies - p. 771 19. Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus - p. 781
